Endotherapy Devices Market
Report ID: SQMIG35A3727
Report ID: SQMIG35A3727
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3727 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
89
|Figures:
76
Global Endotherapy Devices Market size was valued at USD 4.9 Billion in 2024 and is poised to grow from USD 5.25 Billion in 2025 to USD 9.08 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).
The endotherapy devices market includes the instruments and consumables used in diagnosing and treating illnesses using an endoscope. Types of devices included in this market are clips, stents, ablation catheters, balloons, and bariatric balloons. The growth of this market is primarily driven by the global trend toward minimally invasive treatments that offer faster recovery time, reduced risk of infection, and lower cost to hospitals. As a consequence, physicians and payers will increasingly choose to use endoscopes to perform procedures. The endotherapy devices market represents a means of providing less invasive surgical alternatives to open surgery for gastrointestinal disease while evolving from rigid endoscopy systems to high definition (HD) flexible endoscopy systems paired with therapeutic tools. The endotherapy devices market has developed from the use of methods like clips placed over the stomach to control bleeding and losing weight to using methods like placing an intragastric balloon in the stomach to help lose weight, which also demonstrates the evolution of the technology.
The development of safer and more cost-effective ways to treat patients has provided the basis for accelerating innovation in endotherapy devices, as new technologies such as high-resolution imaging, thinner endoscope models, and more advanced/complex endotherapy device accessory technologies to drive the volume of procedures performed. As a result, the availability of advanced endotherapy tools is making endoscopic submucosal dissection and endoscopic sleeve gastrectomy capable alternatives to existing invasive surgical procedures, thus reducing length of hospital stay and creating increased demand for specialized clips and suturing systems and disposable tools designed for specific procedures. Concurrently, favorable reimbursement policies and the proliferation of outpatient endoscopy centers incentivize hospitals and ambulatory providers to acquire endotherapy platforms, while regulatory approvals in emerging markets open patient pools and create a reinforcing cycle of development and adoption globally.
How is AI Enhancing Diagnostic Accuracy In The Endotherapy Devices Market?
The latest artificial intelligence (AI) technology is adding to the information available about endotherapy devices by integrating computer-aided detection (CAD) and computer-aided diagnosis (CAD) combined with advanced imaging processing and clinical decision support (CDS). The significant contribution that AI makes to improving accuracy in diagnosis for the endotherapy device market is the addition of image-based machine learning, additional integration of the endoscopy platform and additional workflows that are automated to decrease variability between observers and allow for an earlier identification of subtle lesions as compared to using just visual inspection.
Current research has resulted in greater clinical validation and regulatory acceptance of CAD and CAD systems are shifting from pilots into devices that are fully integrated into platforms and also can be cloud-based. As a result of AI's contribution to endotherapy devices, procedural consistency is increased, clinical owners focus on targeted biopsy procedures, and provide a higher level of patient care. The EAGLE Study was performed by Olympus February 2026, and used CAD software called CADDIE, which is a cloud-based example of CAD technology that was cleared by the FDA. The results of the EAGLE Study indicate that CADDIE is associated with an increased diagnostic yield of detecting hard lesions and increasing clinical confidence in the future of endotherapy procedures as well as streamlining the reporting process for clinicians.
Market snapshot - (2026-2033)
Global Market Size
USD 4.9 Billion
Largest Segment
GI Endotherapy Devices
Fastest Growth
Others
Growth Rate
7.1% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global endotherapy devices market is segmented by product type, application, end-user and region. Based on product type, the market is segmented into GI Endotherapy Devices and Others. Based on application, the market is segmented into Gastrointestinal Endoscopy, Urology and Others. Based on end-user, the market is segmented into Hospitals, Specialized Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
GI Endotherapy Devices dominate because they provide a solution for both the clinical diagnostic and therapeutic needs associated with gastroenterology (GI). These devices facilitate diagnosis and treatment as part of single clinical visits and enhance clinician workflow and patient care outcomes. The familiarity of clinicians and supporting clinical evidence are key contributing factors to procurement in both hospitals and clinics; on top of these, the investment of manufacturers and R&D has further enabled device performance and reliability which reinforces clinician preference and leads to an increased rate of adoption over time across the healthcare continuum.
Conversely, other devices are emerging rapidly due to the growing number of manufacturers that are designing niche and cross specialty endotherapy devices to meet unmet requirements. The miniaturization, modularity and clearer regulatory pathways of these devices will allow for greater adoption within additional specialties thereby creating new avenues for procurement and partnering opportunities between suppliers and supporting organizations.
The dominant segment of the market is the Hospital segment, as hospitals are where the most complicated cases take place and have the largest volume of procedures performed requiring advanced endotherapy technology as well as integrated service models. When selecting a device for hospitals, capital budgets, procurement processes and leadership from the clinical side are all critical factors. Evidence generation and education occur primarily at academic centres and teaching hospitals, which strengthens vendor relationships, channels and the overall investments into new technology for the hospital market through ongoing use of these centres.
On the other hand, the fastest growing segment of the market is the Ambulatory Surgical Centres (ASC) segment, as there is an ongoing shift to performing more of the endoscopic procedures on an outpatient basis. Therefore, devices are being developed specifically for these patients who need compact devices that are cost efficient. Because there are less costs of operating in ASC's, workflows are streamlined and that physician's prefer to perform procedures that can be completed on that same day, the establishment of new products and processes in ASC's is taking place at a much quicker pace, which creates innovative new products and services for outpatient care.
To get detailed segments analysis, Request a Free Sample Report
The Endotherapy Devices Market in North America is largely driven by a number of forces, including a dense ecosystem of established medical device manufacturers and research institutions, regular clinical trials and product developments; established pathways for reimbursement; and streamlined regulatory processes that are conducive to commercializing healthcare technologies. Furthermore, due to the prevalence of health systems emphasizing minimally invasive techniques, the large number of endotherapy products requires an extended knowledge base and technical skill set to use, therefore creating increased demand for an adequate supply of advanced endotherapy devices and the associated training for their application. Robust capital markets serve as catalysts in providing financing for the scale-up and distribution of medical devices across various points of care as well as enabling companies to enter into strategic partnerships. The existence of a densely populated network of key opinion leaders, professional societies and specialized training facilities greatly facilitates the adoption of new medical devices. Extensive supplier networks and specialized manufacturing facilities guarantee a consistent supply of endotherapy devices, in addition to providing customization for the various clinical settings' needs, while working closely with payors and hospitals ensures that new devices are adopted in both acute and ambulatory care settings.
The Endotherapy Devices Market in the United States has developed through a collective ecosystem of innovators, niche manufacturers, and academic medical centers which influence device adoption and ensure an effective clinical trial process. The synergy among the industry and the clinical champion accelerates device improvement and evidence generation through payer collaborations and reimbursement structures that facilitate both inpatient and outpatient utilization. Focused training programs and professional societies support development of procedural skill sets and facilitate the continued use of advanced endotherapy devices in all care settings.
In Canada, the Endotherapy Devices Market develops through a coordinated health care system characterized by strong relationships between academic medical centers and regional facilities, providing opportunities for clinical adoption of new technologies and for training and development of clinicians using these devices. Collaborative initiatives between regional distributors and global manufacturers facilitate the transfer of technology to care providers in various locations. Adherence to guidelines and synthesis of evidence encourages the utilization of techniques across all sites. Continued clinician training and development of clinical centers of excellence support the continued utilization of endotherapy devices in both the surgical and outpatient settings.
Europe is experiencing rapid expansion of the Endotherapy Devices Market driven by a combination of technological capability, integrated clinical networks, and market maturation across key national systems. Strong engineering and manufacturing capacity, particularly concentrated in leadership markets, fuels product development and customization for regional clinical needs. Harmonization of regulatory frameworks and collaborative clinical research initiatives facilitate cross border clinical adoption and distribution. Health systems emphasize minimally invasive approaches and ambulatory care, encouraging procurement of advanced endotherapy solutions. Growing focus on evidence based guidelines, clinician training, and center level specialization supports broader uptake. Additionally, strategic alliances between local players and global vendors, together with investments in digital enablement and service support models, are expanding access and increasing operational readiness across varied care settings.
Endotherapy Devices Market in Germany benefits from a deep industrial base and precision engineering that support device design and manufacturing. Collaboration between university hospitals and technology firms fosters rigorous clinical evaluation and iterative design. A structured procurement environment and emphasis on clinical guidelines enable adoption in specialized centers. Concentrated training infrastructures and active professional societies promote procedural excellence and support domestic innovation in endotherapy technologies.
Endotherapy Devices Market in United Kingdom is characterized by strong clinical adoption supported by an active innovation ecosystem and policy focus on minimally invasive care. Collaboration between academic centers, medtech companies, and national health service procurement fosters rapid adoption and deployment. Investment in clinician training and digital support enhances confidence in technologies. Partnerships with global vendors and emphasis on real world evidence accelerate integration across hospital trusts and outpatient settings.
Endotherapy Devices Market in France is evolving as clinical centers and regional hospitals increase adoption of minimally invasive procedures. A supportive research environment and engagement between local manufacturers and university hospitals enable pilot studies and adoption. Refinement of reimbursement pathways and national health assessment frameworks is improving access to innovative devices. Emphasis on clinician training, centers of expertise, and collaboration with international vendors strengthens the market foundation for broader uptake.
Asia Pacific is strengthening its position in the Endotherapy Devices Market through a combination of domestic capability building, regulatory modernization, and expanding clinical demand across diverse healthcare systems. Local manufacturers are improving technical sophistication and aligning products to regional procedural preferences, while multinational firms pursue strategic partnerships and technology transfers to scale presence. Governments and private health systems are investing in infrastructure and clinician training to support minimally invasive approaches, and regulatory agencies are streamlining pathways to enable responsible market entry. Growing networks of specialty centers and targeted reimbursement pilots are facilitating evidence generation and practical adoption. Enhanced digital enablement and telemedicine integration are supporting remote training and procedural planning, while cost conscious procurement models encourage affordable innovation tailored to local needs.
Endotherapy Devices Market in Japan is anchored by advanced medical technology capabilities and precision engineering that support device design and manufacturing. Collaboration between leading hospitals, research institutions, and domestic manufacturers enables rigorous clinical validation and refinement. Health system focus on minimally invasive approaches and coordinated training programs supports procedural competence. Strong regulatory standards and reimbursement mechanisms facilitate adoption across tertiary centers, where integration with imaging and procedural platforms is common.
Endotherapy Devices Market in South Korea benefits from dynamic technology sector and medtech startup community that drive product development and commercialization. Partnerships between domestic manufacturers, academic hospitals, and international vendors enable technology transfer and trials. Government support for medical innovation and strong hospital networks facilitate adoption and clinician training. Focus on integration with digital platforms and device design positions the market for scalable deployment across specialized centers and clinical settings.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Adoption Of Minimally Invasive Techniques
Advances In Imaging and Navigation
High Cost Of Devices and Procedures
Complex Regulatory and Reimbursement Pathways
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape for the global endotherapy devices market is defined by platform consolidation through targeted M&A, deep clinical partnerships, and rapid device innovation. Notable examples include Ethicon's acquisition of Auris Health to add robotic endoluminal capability, startups forming institutional collaborations to accelerate clinical validation, and incumbent vendors pursuing expedited product clearances and integration of AI and robotic modules to defend procedure ecosystems.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global endotherapy devices market is propelled by growing adoption of minimally invasive techniques and advances in imaging and AI-enabled diagnostics, which expand therapeutic indications and improve detection and workflow. Adoption is moderated by the high cost of devices and procedures that constrains procurement in resource limited settings. North America remains the dominant region due to strong innovation hubs, clear reimbursement pathways and concentrated clinical expertise. GI endotherapy devices lead the market as they deliver single procedure diagnosis and treatment for core gastrointestinal conditions. Continued outpatient migration and digital integration will shape near term product demand and vendor strategies.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 4.9 Billion |
| Market size value in 2033 | USD 9.08 Billion |
| Growth Rate | 7.1% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Endotherapy Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Endotherapy Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Endotherapy Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Endotherapy Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Endotherapy Devices Market size was valued at USD 4.9 Billion in 2024 and is poised to grow from USD 5.25 Billion in 2025 to USD 9.08 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).
The competitive landscape for the global endotherapy devices market is defined by platform consolidation through targeted M&A, deep clinical partnerships, and rapid device innovation. Notable examples include Ethicon's acquisition of Auris Health to add robotic endoluminal capability, startups forming institutional collaborations to accelerate clinical validation, and incumbent vendors pursuing expedited product clearances and integration of AI and robotic modules to defend procedure ecosystems. 'Olympus Corporation', 'Boston Scientific Corporation', 'Medtronic', 'Fujifilm Holdings', 'Cook Medical', 'Karl Storz SE & Co KG', 'Stryker Corporation', 'Smith & Nephew', 'Johnson & Johnson', 'HOYA Corporation', 'CONMED Corporation', 'Nipro Corporation', 'Richard Wolf GmbH', 'B. Braun SE', 'Steris Corporation', 'Halyard Health', 'Merit Medical Systems', 'Teleflex', 'Cantel Medical', 'Micro-Tech Nanjing'
A broad shift toward minimally invasive procedures encourages healthcare providers to prefer endotherapy devices because these tools facilitate targeted treatment with reduced tissue trauma and faster patient recovery. By enabling complex interventions through natural orifices and small access points, endotherapy devices lower procedural burden and support expanded clinical indications. Improved patient comfort and shorter hospital stays bolster clinician willingness to adopt such technologies, while device versatility and compatibility with adjunct imaging make them integral to modern procedure pathways, thereby sustaining ongoing investment and procurement by health systems.
Minimally Invasive Procedure Uptake: Surgeon and patient preference for less invasive approaches is accelerating adoption of endotherapy devices across specialties. Improved procedural ergonomics and shorter recovery expectations are prompting providers to incorporate advanced catheters and endoscopes into care pathways. Manufacturers focus on intuitive designs and single-use options to simplify workflows and broaden clinician acceptance. Increased training initiatives and interdisciplinary collaboration support clinical adoption, enabling procedures to migrate from hospital operating rooms to ambulatory settings, expanding access while maintaining focus on patient safety and outcomes.
Why does North America Dominate the Global Endotherapy Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
